What is Kyverna Therapeutics, Inc.'s enterprise value?

Kyverna Therapeutics, Inc. (KYTX) reported enterprise value of $498.7M in Q1 2026.

How has Kyverna Therapeutics, Inc.'s enterprise value changed year-over-year?

Kyverna Therapeutics, Inc.'s enterprise value increased by 1393.4% year-over-year, from $33.39M to $498.7M.

What does enterprise value mean?

Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.

Kyverna Therapeutics, Inc. KYTX Enterprise value

Enterprise value at other companies

Bristol-Myers SquibbBMY

$158.92B-2.6%

Gilead SciencesGILD

$187.53B+19.7%

Climb Bio, Inc.CLYM

$319.33M+494%

Artiva Biotherapeutics, Inc.ARTV

$148.02M+163%

Iovance Biotherapeutics, Inc.IOVA

$1.3B+33.2%

Viridian Therapeutics, Inc.VRDN

$1.86B+85.0%

Other financials

Income statement

See full

Operating income-$41.4M+12.7%

Net income-$39.7M+11.0%

EPS (diluted)-$0.66+35.9%

Balance sheet

See full

Cash & equivalents$32.2M-43.4%

Total debt$9.2M+32.1%

Total equity$195.6M-12.7%

Total assets$257.0M-1.4%

Cash flow

See full

Operating cash flow-$41.6M+7.4%

CapEx$2.0K-98.0%

Free cash flow-$33.5M+10.8%

Valuation

See full

Market cap$498.52M+276%

Returns & leverage

See full

Return on equity-74.5%+74.4pp

Debt / equity0×0.0×

Current ratio8.1×+0.7×

Where this comes from

Calculated from Kyverna Therapeutics, Inc.’s reported figures.

$521.7Mmarket cap+$9.2Mtotal debt−$32.2Mcash and equivalents=$498.7M

The official record: Kyverna Therapeutics, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kyverna Therapeutics, Inc.'s enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Kyverna Therapeutics, Inc.'s enterprise value?: Kyverna Therapeutics, Inc. (KYTX) reported enterprise value of $498.7M in Q1 2026.
How has Kyverna Therapeutics, Inc.'s enterprise value changed year-over-year?: Kyverna Therapeutics, Inc.'s enterprise value increased by 1393.4% year-over-year, from $33.39M to $498.7M.
What does enterprise value mean?: Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.